These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 1829469)

  • 1. Duration of response to intramuscular versus low dose intradermal hepatitis B booster immunization.
    McKinney WP; Russler SK; Horowitz MM; Battiola RJ; Lee MB
    Infect Control Hosp Epidemiol; 1991 Apr; 12(4):226-30. PubMed ID: 1829469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intramuscular vs intradermal route for hepatitis B booster vaccine in celiac children.
    Leonardi S; Praticò AD; Lionetti E; Spina M; Vitaliti G; La Rosa M
    World J Gastroenterol; 2012 Oct; 18(40):5729-33. PubMed ID: 23155313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistence of hepatitis B surface antibody and immune memory to hepatitis B vaccine among medical college students in Madinah.
    Mahallawi W
    Ann Saudi Med; 2018; 38(6):413-419. PubMed ID: 30531175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative long term immunogenicity of two recombinant hepatitis B vaccines and the effect of a booster dose given after five years in a low endemicity country.
    Duval B; Gîlca V; Boulianne N; De Wals P; Massé R; Trudeau G; De Serres G
    Pediatr Infect Dis J; 2005 Mar; 24(3):213-8. PubMed ID: 15750456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up of hepatitis B vaccination in susceptible hospital personnel.
    Chan CY; Lee SD; Tsai YT; Lo KJ
    J Gastroenterol Hepatol; 1992; 7(3):266-9. PubMed ID: 1535229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the response to a booster dose of hepatitis B vaccine in previously immunized healthcare workers.
    Williams JL; Christensen CJ; McMahon BJ; Bulkow LR; Cagle HH; Mayers JS; Zanis CL; Parkinson AJ; Margolis HS
    Vaccine; 2001 Jul; 19(28-29):4081-5. PubMed ID: 11427285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B immunity and response to booster vaccination in children with inflammatory bowel disease treated with infliximab.
    Moses J; Alkhouri N; Shannon A; Raig K; Lopez R; Danziger-Isakov L; Feldstein AE; Zein NN; Wyllie R; Carter-Kent C
    Am J Gastroenterol; 2012 Jan; 107(1):133-8. PubMed ID: 21876562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of booster dose vaccination 21- to 32-years after primary vaccination with hepatitis B vaccine in the population born from 1986 to 1996 in Zhengding County of Hebei Province].
    Zhang XJ; Wu ZW; Zhang YH; Li MJ; Zhou HS; Han BH; Hao ZY; Chu J; Gao Z; Ma JC; Zhao YL
    Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Sep; 54(9):942-946. PubMed ID: 32907282
    [No Abstract]   [Full Text] [Related]  

  • 9. Persistence of antibody to hepatitis B surface antigen after low-dose, intradermal hepatitis B immunization and response to a booster dose.
    Bryan JP; Sjogren MH; Macarthy P; Cox E; Legters LJ; Perine PL
    Vaccine; 1992; 10(1):33-8. PubMed ID: 1531719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous passive and active immunization against hepatitis B: noninterference of hepatitis B immune globulin with the anti-HBs response to reduced doses of heat-inactivated hepatitis B vaccine.
    Lelie PN; Reesink HW; Grijm R; de Jong-van Manen ST; Reerink-Brongers EE
    Hepatology; 1986; 6(5):971-5. PubMed ID: 3758947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B immune memory in children primed with hexavalent vaccines and given monovalent booster vaccines: an open-label, randomised, controlled, multicentre study.
    Zanetti AR; Romanò L; Giambi C; Pavan A; Carnelli V; Baitelli G; Malchiodi G; Valerio E; Barale A; Marchisio MA; Montù D; Tozzi AE; D'Ancona F;
    Lancet Infect Dis; 2010 Nov; 10(11):755-61. PubMed ID: 20884297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antibody persistence following booster vaccination with three doses of hepatitis B vaccines among low-response adults in Zhangqiu county of Shandong province: 24-month of follow-up from 2009].
    Yan B; Lyu J; Liu J; Feng Y; Xu A; Chen S; Zhou L; Liang X; Cui F; Wang F; Zhang L
    Zhonghua Yu Fang Yi Xue Za Zhi; 2014 Dec; 48(12):1043-7. PubMed ID: 25619213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccines for preventing hepatitis B in health-care workers.
    Chen W; Gluud C
    Cochrane Database Syst Rev; 2005 Oct; (4):CD000100. PubMed ID: 16235273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intramuscular versus low-dose intradermal hepatitis B vaccine. Assessment by humoral and cellular immune response to hepatitis B surface antigen.
    Frazer IH; Jones B; Dimitrakakis M; Mackay IR
    Med J Aust; 1987 Mar; 146(5):242-5. PubMed ID: 2950303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Durability of antibody response against hepatitis B virus in healthcare workers vaccinated as adults.
    Gara N; Abdalla A; Rivera E; Zhao X; Werner JM; Liang TJ; Hoofnagle JH; Rehermann B; Ghany MG
    Clin Infect Dis; 2015 Feb; 60(4):505-13. PubMed ID: 25389254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trial of hepatitis B vaccine in a simplified immunization programme.
    Coursaget P; Yvonnet B; Sarr M; Vincelot P; Tortey E; Mboup S; Chiron JP; Diop-Mar I
    Bull World Health Organ; 1986; 64(6):867-71. PubMed ID: 2951032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose (2 micrograms) hepatitis B vaccination in medical students: comparable immunogenicity for intramuscular and intradermal routes.
    Heijtink RA; Knol RM; Schalm SW
    J Med Virol; 1989 Feb; 27(2):151-4. PubMed ID: 2522147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duration of immunity after hepatitis B vaccination: efficacy of low-dose booster vaccine.
    Horowitz MM; Ershler WB; McKinney WP; Battiola RJ
    Ann Intern Med; 1988 Feb; 108(2):185-9. PubMed ID: 2963570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody Levels and Protection After Hepatitis B Vaccine: Results of a 30-Year Follow-up Study and Response to a Booster Dose.
    Bruce MG; Bruden D; Hurlburt D; Zanis C; Thompson G; Rea L; Toomey M; Townshend-Bulson L; Rudolph K; Bulkow L; Spradling PR; Baum R; Hennessy T; McMahon BJ
    J Infect Dis; 2016 Jul; 214(1):16-22. PubMed ID: 26802139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune persistence 17 to 20 years after primary vaccination with recombination hepatitis B vaccine (CHO) and the effect of booster dose vaccination.
    Zhao YL; Han BH; Zhang XJ; Pan LL; Zhou HS; Gao Z; Hao ZY; Wu ZW; Ma TL; Wang F; Li Q; Bi SL; Ma JC
    BMC Infect Dis; 2019 May; 19(1):482. PubMed ID: 31146699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.